Abstract: A process for the manufacture of omeprazole or esomeprazole from pyrmethyl alcohol via pyrmethyl chloride and pyrmetazole characterized in that the whole reaction sequence is carried out without any isolation or purification of intermediates. Further, the reaction is carried out in a solvent system common for the whole reaction sequence and inert to the reactants formed during the process and used in the process and comprises a water immiscible organic solvent and a specified amount of water.

Abstract: A storage apparatus is proposed for facilitating wireless communication between a computer device and one or more external portable electronic devices, or between those external devices. The storage apparatus includes a wireless transceiver for entering communication with any of one the devices. When the storage apparatus is communicating with any of the devices, it can transmit to that device any data stored in its memory for transmission to that device. Furthermore, the storage apparatus can receive from that device, and transmit to its memory, data to be relayed to another of the devices.

Abstract: A portable memory device is provided that is capable of easy connection to a personal computer via a universal serial bus (USB) port, IEEE 1394 (i.e., firewire) or similar port. Included in the portable memory device is a compression/decompression engine capable of compressing and decompressing data. Data residing on a personal computer or other host platform is compressed by the engine and saved to the memory of the portable memory device. Compressed data is retrieved and decompressed by the engine and transmitted to the personal computer for use by the user. Embodiments of the present invention thus provide a highly convenient system and apparatus for users to access and save larger quantities of data to a relatively small device.

Abstract: A method of making a lead frame and a partially patterned lead frame package with near-chip scale packaging (CSP) lead-counts is accomplished by performing a major portion of the manufacturing process steps with a partially patterned strip of metal formed into a web-like lead frame on one side, so that the web-like lead frame, which is solid and flat on the other side is also rigid mechanically and robust thermally to perform without distortion or deformation during the chip-attach and wire bond processes, both at the chip level and the package level. The bottom side of the metal lead frame is patterned to isolate the chip-pad and the wire bond contacts only after the front side, including the chip and wires, is encapsulated. The resultant package being electrically isolated enables strip testing and reliable singulation without having to cut into any additional metal.

Abstract: A control system for a first window lifter adjusts a first window pane of a motor vehicle having a first drive, and for a second window lifter for adjusting a second window pane of the motor vehicle having a second drive, having a control device. The control device may be electrically connected both to the first drive and to the second drive for the purpose of energization. The control device may have a first sensor for determining a first adjustment position of the first window lifter, and a second sensor for determining a second adjustment position of the second window lifter, the first sensor and the second sensor being based on different physical operational principles.

Abstract: An amplifier for electric guitar including a plurality of foot switch selectable preamplifier channels which can be set to provide differing sonic characteristics, and also including a power amplifier section for driving a loudspeaker that can be switched between at least two different power or performance capabilities. User operable switching dedicated to at least one of the preamplifier channels is provided to select preferred power amplifier parameters in conjunction with differing channel voicings. Thus, differing preferred power amplifier characteristics may be pre-set and assigned to individual preamplifier channels and called up automatically in conjunction with the remote channel selection.

Abstract: A method for providing data access control over information networks comprises coupling a control device to a digital processing system, obtaining user identification by executing a user authentication process, retrieving initialization information from a first memory unit of the control device in response to a request from an information provider received over the information network when user's identity is authenticated, providing the initialization information to the information provider via the information network through the digital processing system, establishing a communication between the control device and the information provider over the information network when an acknowledgement of user identity is received, obtaining information from the information provider over the information network, and storing the information in a second memory unit of the control device.

Abstract: The invention relates to the composition of fresh concrete and admixtures for fresh concrete and can be used in the construction industry for producing monolithic and precast concrete and reinforced concrete structures, in spraying mixtures and also in the oil extraction industry when producing injection and insulation cement materials.

Abstract: The present invention relates to new salts of the single enantiomers of omeprazole, i.e. salts of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole ((S)-omeprazole) and (R)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole ((R)-omeprazole) respectively. More specifically, the present invention relates to 1-cyclohexylethyl ammonium salts of the compounds, formed by a reaction of (S)-omeprazole and (R)-omeprazole respectively and 1-cyclohexylethyl amine. The present invention also relates to a process for preparing the compounds of the invention, a pharmaceutical preparation and a method for treatment of gastric related disorders by administering the compounds of the invention.

Abstract: The invention relates to a new process for the production of alkyl dialkoxyalkylphosphinates. A hypophosphite salt is used in the process.

Abstract: A tri-level authentication process comprises performing a biometrics-based authentication of a user of a portable device, performing an authentication handshake between the portable device and a content server, wherein the portable device includes a USB plug that plugs directly into a USB port of a host computer and the host computer is communicatively coupled to the content server, and performing a user authentication using a first key sent from the portable device to the content server, wherein access to restricted content on the content server by the user is enabled if the biometrics-based authentication, the authentication handshake, and the user authentication using a first key are all successful. The process may also include encrypting restricted content received from the content server using a private key before storing the restricted content in a non-volatile memory of the portable device.

Abstract: Apparatus and method for implementing biometrics-based access control to a restricted resource. In a preferred embodiment, the present invention is realized using a portable device. Specifically, in one embodiment, the portable device includes a microprocessor, a non-volatile memory coupled thereto, and a biometrics-based authentication module controlled by the microprocessor. Preferably, the biometrics technology used is fingerprint authentication technology. The authentication module is capable of registering a fingerprint upon first use of the portable device, storing an encoded version of the fingerprint in the non-volatile memory. Subsequently, the authentication module can read a person's fingerprint and reliably determine whether the fingerprint matches the registered fingerprint stored in the non-volatile memory. If a match is found, access to the restricted resource is granted to that person; otherwise, access is denied.

Abstract: The present invention relates to a method and system for dosing a pharmaceutical product in a packaging machine having at least one volumetric dosing unit with a dosing chamber. The system check-weighs the volumetrically dosed product with appropriate speed and is integrated into a filling or packaging machine. In accordance with the invention, a volume of a first pharmaceutical component is metered and weighed before being introduced into a package. The procedure is repeated with a second pharmaceutical component. The package containing the components is then weighed. Advantageously, accuracy and precision of the amount of the weighed components can be monitored with the present invention to secure the quality of the pharmaceutical product.

Abstract: The rocker machine of the invention can be worked to produce uniformly engraved plates of any size and suitable for mezzotint engraving. The rocker machine includes a table, a rocker assembly and a guide assembly. The table can be rotatable or fixed, and is inclined at an angle to the horizontal. The rocker assembly includes one or more rockers, one or more lateral members and a cross arm. Each rocker has a curved lower edge along which protrude a plurality of teeth. The lateral members are adapted for reciprocal translation along a horizontal axis, and are moveable along an axis substantially perpendicular to the plane of the rocker. The lateral members are attached at the proximal end to the rocker or to the cross arm and at the distal end are moveable along lateral guides.

Abstract: The present invention relates to a novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole, known under the generic name omeprazole. Further, the present invention also relates to the use of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H -benzimidazole for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole.

Abstract: New non-ionic surfactants in the form of polyoxyalkylene glycol hydroxy fatty acid derivatives or monoalkylated polyoxyalkylene glycol hydroxy fatty acid derivatives having a polyoxyalkylene/alkyl polyoxyalkylene chain with a chain-length of 25-455 repeating units and a specified substituent on the hydroxy position of the specified hydroxy fatty acid, according to the general formula (I) CH3—(CH2)x—CH—(CH2)y—CO—[—O—R3—]z—O—R1 R2—O (I); wherein for example R1 is methyl, R2 is optionally substituted C14-C22 acyl, alkyl, or alkenyl, R3 is ethylene, x is 2-12, y is 7-17, (x+y) is 3-19 and z is 25-57; advantageously prepared by involving an enzymatic process, formulations comprising them, their use as solubilizers and a process involving a hydrolytic enzyme for preparing them.

Abstract: An oral pharmaceutical dosage form comprising an acid susceptible proton pump inhibitor and one or more NSAIDs in a fixed formulation, wherein the proton pump inhibitor is protected by an enteric coating layer. The fixed formulation is in the form of an enteric coating layered tablet, a capsule or a multiple unit tableted dosage form. The multiple unit dosage forms are most preferred. The new fixed formulation is especially useful in the treatment of gastrointestinal side-effects associated with NSAID treatment.